BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fan B, Chopp M, Zhang ZG, Liu XS. Treatment of diabetic peripheral neuropathy with engineered mesenchymal stromal cell-derived exosomes enriched with microRNA-146a provide amplified therapeutic efficacy. Exp Neurol 2021;341:113694. [PMID: 33727097 DOI: 10.1016/j.expneurol.2021.113694] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yamaguchi H, Kawahara H, Kodera N, Kumaki A, Tada Y, Tang Z, Sakai K, Ono K, Yamada M, Hanayama R. Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis. Front Mol Biosci 2022;9:839917. [DOI: 10.3389/fmolb.2022.839917] [Reference Citation Analysis]
2 Martinez-arroyo O, Ortega A, Forner MJ, Cortes R. Mesenchymal Stem Cell-Derived Extracellular Vesicles as Non-Coding RNA Therapeutic Vehicles in Autoimmune Diseases. Pharmaceutics 2022;14:733. [DOI: 10.3390/pharmaceutics14040733] [Reference Citation Analysis]
3 Ashrafizadeh M, Kumar A, Aref AR, Zarrabi A, Mostafavi E. Exosomes as Promising Nanostructures in Diabetes Mellitus: From Insulin Sensitivity to Ameliorating Diabetic Complications. IJN 2022;Volume 17:1229-53. [DOI: 10.2147/ijn.s350250] [Reference Citation Analysis]
4 Xu J, Zuo C. The Fate Status of Stem Cells in Diabetes and its Role in the Occurrence of Diabetic Complications. Front Mol Biosci 2021;8:745035. [PMID: 34796200 DOI: 10.3389/fmolb.2021.745035] [Reference Citation Analysis]
5 Chiang JCB, Arnold R, Dhanapalaratnam R, Markoulli M, Krishnan AV. Current and Emerging Pharmacotherapeutic Interventions for the Treatment of Peripheral Nerve Disorders. Pharmaceuticals 2022;15:607. [DOI: 10.3390/ph15050607] [Reference Citation Analysis]
6 Barutta F, Corbetta B, Bellini S, Guarrera S, Matullo G, Scandella M, Schalkwijk C, Stehouwer CD, Chaturvedi N, Soedamah-Muthu SS, Durazzo M, Gruden G. MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS. J Transl Med 2021;19:475. [PMID: 34823560 DOI: 10.1186/s12967-021-03142-4] [Reference Citation Analysis]
7 Brady L, Pai S, Iaquinto JM, Wang YN, Ledoux WR. The compressive, shear, biochemical, and histological characteristics of diabetic and non-diabetic plantar skin are minimally different. J Biomech 2021;129:110797. [PMID: 34688066 DOI: 10.1016/j.jbiomech.2021.110797] [Reference Citation Analysis]
8 Gada Y, Pandey A, Jadhav N, Ajgaonkar S, Mehta D, Nair S. New Vistas in microRNA Regulatory Interactome in Neuropathic Pain. Front Pharmacol 2022;12:778014. [DOI: 10.3389/fphar.2021.778014] [Reference Citation Analysis]
9 Aneesh A, Liu A, Moss HE, Feinstein D, Ravindran S, Mathew B, Roth S. Emerging concepts in the treatment of optic neuritis: mesenchymal stem cell-derived extracellular vesicles. Stem Cell Res Ther 2021;12:594. [PMID: 34863294 DOI: 10.1186/s13287-021-02645-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Momma S. Extracellular vesicles for remote brain repair. Curr Opin Genet Dev 2021;70:61-5. [PMID: 34153928 DOI: 10.1016/j.gde.2021.06.001] [Reference Citation Analysis]
11 Chen S, Sun F, Qian H, Xu W, Jiang J, Bruno S. Preconditioning and Engineering Strategies for Improving the Efficacy of Mesenchymal Stem Cell-Derived Exosomes in Cell-Free Therapy. Stem Cells International 2022;2022:1-18. [DOI: 10.1155/2022/1779346] [Reference Citation Analysis]